104 related articles for article (PubMed ID: 1403719)
1. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.
Borgström L; Newman S; Weisz A; Morén F
J Pharm Sci; 1992 Aug; 81(8):753-5. PubMed ID: 1403719
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler.
Newman S; Steed K; Hooper G; Källén A; Borgström L
Pharm Res; 1995 Feb; 12(2):231-6. PubMed ID: 7784338
[TBL] [Abstract][Full Text] [Related]
3. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.
Borgström L; Bondesson E; Morén F; Trofast E; Newman SP
Eur Respir J; 1994 Jan; 7(1):69-73. PubMed ID: 8143834
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.
Abdelrahim ME; Assi KH; Chrystyn H
Br J Clin Pharmacol; 2011 Apr; 71(4):608-10. PubMed ID: 21395654
[TBL] [Abstract][Full Text] [Related]
5. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline.
Borgström L; Nilsson M
Pharm Res; 1990 Oct; 7(10):1068-70. PubMed ID: 2281038
[TBL] [Abstract][Full Text] [Related]
6. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
Abdelrahim ME
Respir Med; 2010 May; 104(5):682-9. PubMed ID: 20004090
[TBL] [Abstract][Full Text] [Related]
7. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler.
Newman SP; Morén F; Trofast E; Talaee N; Clarke SW
Eur Respir J; 1989 Mar; 2(3):247-52. PubMed ID: 2731602
[TBL] [Abstract][Full Text] [Related]
8. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
Derom E; Borgström L; Van Schoor J; Löfroos AB; Pauwels R
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1398-402. PubMed ID: 11704585
[TBL] [Abstract][Full Text] [Related]
9. The inhalation device influences lung deposition and bronchodilating effect of terbutaline.
Borgström L; Derom E; Ståhl E; Wåhlin-Boll E; Pauwels R
Am J Respir Crit Care Med; 1996 May; 153(5):1636-40. PubMed ID: 8630614
[TBL] [Abstract][Full Text] [Related]
10. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.
Mortensen J; Groth S; Lange P; Hermansen F
Thorax; 1991 Nov; 46(11):817-23. PubMed ID: 1771605
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma.
Laberge S; Spier S; Drblik SP; Turgeon JP
J Pediatr; 1994 May; 124(5 Pt 1):815-7. PubMed ID: 8176575
[TBL] [Abstract][Full Text] [Related]
12. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
Lähelmä S; Kirjavainen M; Kela M; Herttuainen J; Vahteristo M; Silvasti M; Ranki-Pesonen M
Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
[TBL] [Abstract][Full Text] [Related]
13. Effect of inhaled terbutaline sulphate in relation to its deposition in the lungs.
Hultquist C; Wollmer P; Eklundh G; Jonson B
Pulm Pharmacol; 1992 Jun; 5(2):127-32. PubMed ID: 1611230
[TBL] [Abstract][Full Text] [Related]
14. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler.
Ekström T; Andersson AC; Skedinger M; Lindbladh C; Ståhl E
Ann Allergy Asthma Immunol; 1995 Apr; 74(4):328-32. PubMed ID: 7719894
[TBL] [Abstract][Full Text] [Related]
15. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
[TBL] [Abstract][Full Text] [Related]
16. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
17. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
[TBL] [Abstract][Full Text] [Related]
19. Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation.
Krogh N; Rzeppa S; Dyreborg A; Dehnes Y; Hemmersbach P; Backer V; Hostrup M
Med Sci Sports Exerc; 2017 Jun; 49(6):1236-1243. PubMed ID: 28072631
[TBL] [Abstract][Full Text] [Related]
20. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
Pitcairn G; Reader S; Pavia D; Newman S
J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
